IP Library Granted Patent US 12,215,202
Granted Patent B2
US 12,215,202 · App. 18/196,884 · Granted Feb 4, 2025

Additive manufacturing support material

Inventors: Andrew Hudson (Pittsburgh, PA); Thomas Hinton (Pittsburgh, PA); Adam Feinberg (Pittsburgh, PA); Andrew Lee (Pittsburgh, PA)
Assignee: Carnegie Mellon University
C08J3/075B33Y70/00C09D11/04B29C64/40C08J2389/00C08J2389/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,215,202
App. No.
18/196,884
Granted
Feb 4, 2025
Kind
B2
Abstract

This document describes a process of producing gel microparticles, which are consistent in size and morphology. Through the process of coacervation, large volumes of gel microparticle slurry can be produced by scaling up reactor vessel size. Particles can be repeatedly dehydrated and rehydrated in accordance to their environment, allowing for the storage of particles in a non-solvent such as ethanol. Gel slurries exhibit a Bingham plastic behavior in which the slurry behaves as a solid at shear stresses that are below a critical value. Upon reaching the critical shear stress, the slurry undergoes a rapid decrease in viscosity and behaves as a liquid. The rheological behavior of these slurries can be adjusted by changing the compaction processes such as centrifugation force to alter the yield-stress. The narrower distribution and reduced size of these particles allows for an increase in FRESH printing fidelity.

Claims (18)

1. A support material for additive manufacturing comprising:

a solution; and

particles in the solution, the particles being of substantially uniform geometries;

wherein at least a portion of the solution forms a rigid body when experiencing a stress below a threshold stress;

wherein a value of the threshold stress is based on the substantially uniform geometries of the particles; and

wherein at least a portion of the solution forms a viscous fluid when experiencing a stress above the threshold stress.

2. The support material of claim 1 , wherein a mean size of the particles varies less than 35% for the particles being of substantially uniform geometries.

3. The support material of claim 1 , wherein the solution comprises a surfactant configured to inhibit dendrite formation in the solution.

4. The support material of claim 1 , wherein the particles each comprises at least one of gelatin, alginate, and cellulose.

5. The support material of claim 1 , wherein the particles comprise two or more different polymers.

6. The support material of claim 5 , wherein one of the two or more different polymers comprises gum arabic, and wherein another of the two or more different polymers comprises gelatin.

7. The support material of claim 1 , wherein the solution comprises water as a solvent and ethanol as a co-solvent, and wherein the solution comprises a ratio of the solvent to the co-solvent in a range of 30:70 and 70:30.

8. The support material of claim 1 , wherein a mean size of the particles is between about 0.5 μm and about 60 μm.

9. The support material of claim 1 , wherein the threshold stress comprises a critical shear stress in which a cohesive force between first and second of the particles of the solution is approximately equal to an external shear force applied to the particles of the solution.

10. The support material of claim 9 , wherein a value of the critical shear stress is between about 10 Pa and about 10000 Pa.

11. The support material of claim 9 , wherein a value of the critical shear stress is based on a viscosity of an ink for additive manufacturing in the solution.

12. The support material of claim 11 , wherein the ink comprises collagen.

13. The support material of claim 11 , wherein the particles are approximately monodisperse in the solution.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 17, 2024
From: CARNEGIE-MELON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066340/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2023
From: HUDSON, ANDREW; HINTON, THOMAS; FEINBERG, ADAM; LEE, ANDREW
To: CARNEGIE MELLON UNIVERSITY
Reel/Frame 063640/0585 →
Continuity (4)
Continuation 16603158
Provisional Application 62606578 · Sep 28, 2017
Provisional Application 62601949 · Apr 5, 2017
Related Publication 20240110017A1 · Apr 4, 2024
References Cited (38)
US 2800457A · Green et al. · 1957 [cited by applicant]
US 3242051A · Heistand et al. · 1966 [cited by applicant]
US 3748227A · Wagner et al. · 1973 [cited by applicant]
US 4428869A · Munteanu et al. · 1984 [cited by applicant]
US 6294204B1 · Rossling et al. · 2001 [cited by applicant]
US 11692070B2 · Hudson et al. · 2023 [cited by applicant]
US 20030065400A1 · Beam et al. · 2003 [cited by applicant]
US 20030193102A1 · Yan · 2003 [cited by examiner]
US 20160167312A1 · Feinberg · 2016 [cited by examiner]
US 20200032004A1 · Hudson et al. · 2020 [cited by applicant]
CN 105796478 · 2016 [cited by applicant]
CN 106039411 · 2016 [cited by applicant]
CN 106039414 · 2016 [cited by applicant]
CN 205903442 · 2017 [cited by applicant]
CN 107614264 · 2018 [cited by applicant]
EP 0316054 · 1989 [cited by applicant]
EP 3606658 · 2023 [cited by applicant]
JP S5871879 · 1983 [cited by applicant]
JP 2018500894 · 2018 [cited by applicant]
JP 2020516505 · 2020 [cited by applicant]
WO WO2016090286 · 2016 [cited by applicant]
WO WO2016130953 · 2016 [cited by applicant]
WO WO2018187595 · 2018 [cited by applicant]
Office Action in Japanese Appln. No. 2023-095613, mailed on Jun. 11, 2024, 12 pages (with English translation). [cited by applicant]
Office Action in Mexican Appln. No. MX/a/2019/012004, mailed on Jun. 18, 2024, 8 pages (with Machine translation). [cited by applicant]
Abbadessa, “Thermosensitive hydrogels for 3D bioprinting of cartilage constructs,” Dissertation, Urecht Institute for Pharmaceutical Science, 2017, 219 pages. [cited by applicant]
Database WPI Week 198323 Thomson Scientific, London, GB; AN 1983-55015K XP002798522, & JP S58 71879 A (Snow Brand Milk Prod Co Ltd), Apr. 28, 1983 (Apr. 28, 1983) (abstract). [cited by applicant]
Supplementary Search Report in European Appln. No. 18780662.5, dated Apr. 9, 2020, 11 pages. [cited by applicant]
Gelatin-GMIA.com [online] “The Gelatin Handbook,” 1896, retrieved on Oct. 4, 2019, retrieved from URL: <http://www.gelatin-gmia.com/uploads/1/1/8/4/118450438/gmia_gelatin_manual_2019.pdf, pp. 5-7. [cited by applicant]
Hinton et al., “Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels,” Science advances, 2015, 1(9):e1500758. [cited by applicant]
Hinton, “Rapid Prototyping Tissue Models of Mammary Duct Epithelium,” Thesis for the degree of Doctor of Philosophy in Biomedical Engineering, Carnegie Mellon University, Apr. 2017, 144 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2018/026293, dated Oct. 8, 2019, 8 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2018/26293, mailed on Jun. 13, 2018, pp. 49 pages. [cited by applicant]
Jieying et al., “Theory and Practice of Modern Physical Pharmacy”, Shanghai Science and Technology Literature Press, Apr. 2005, 7 pages (with machine translation). [cited by applicant]
Lemetter et al., “Control of the morphology and the size of complex coacervate microcapsules during scale-up,” Process Systems Engineering, 2009, 55(6):1487-1496. [cited by applicant]
Mohanty et al., “Microscopic structure of gelatin coacervates,” International journal of biological macromolecules, 2005, 36(1-2):39-46. [cited by applicant]
Ruzhi, “Pharmacy”, People's Health Press, Oct. 2000, pp. 353-356, 12 pages (with machine translation). [cited by applicant]
Search Report in European Appln. No. 23164390.9, dated Aug. 24, 2023, 10 pages. [cited by applicant]